window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Movers and Shakers

  • Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics

    Inizio appoints Ryan Quigley as new chief executive officer

    Inizio has appointed Ryan Quigley as its new chief executive [...]

    September 10, 2025
  • Drug Development,Movers & Shakers,Oncology,Rare Diseases,Regulatory Affairs

    Amorphical names Eden Ben CEO to drive regulatory strategy and expand nano-mineral therapeutics pipeline

    Amorphical has appointed Eden Ben as chief executive officer, as [...]

    September 10, 2025
  • Pharmaceuticals and therapeutics

    Genmab names Matt Kiely as UK general manager to spearhead commercial expansion

    Genmab has appointed Matt Kiely as general manager for the [...]

    September 7, 2025
  • Clinical Development,Movers & Shakers,Oncology,RNA Therapeutics

    Strand Therapeutics appoints Jason Luke as chief medical officer

    Strand Therapeutics has appointed oncology researcher Jason Luke as its [...]

    August 26, 2025
Previous56

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top